EXTENDSURE HBFASC CONTROL

Control, Hemoglobin, Abnormal

CANTEBURY SCIENTIFIC LTD.

The following data is part of a premarket notification filed by Cantebury Scientific Ltd. with the FDA for Extendsure Hbfasc Control.

Pre-market Notification Details

Device IDK053031
510k NumberK053031
Device Name:EXTENDSURE HBFASC CONTROL
ClassificationControl, Hemoglobin, Abnormal
Applicant CANTEBURY SCIENTIFIC LTD. 14 POPE STREET Christchurch, Canterbury,  NZ 8001
ContactMaurice Owen
CorrespondentMaurice Owen
CANTEBURY SCIENTIFIC LTD. 14 POPE STREET Christchurch, Canterbury,  NZ 8001
Product CodeJCM  
CFR Regulation Number864.7415 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2005-10-27
Decision Date2005-12-07
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.